Bank of New York Mellon’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$419K Buy
55,474
+2,226
+4% +$16.8K ﹤0.01% 3590
2025
Q1
$294K Sell
53,248
-3,872
-7% -$21.4K ﹤0.01% 3694
2024
Q4
$328K Sell
57,120
-1,007
-2% -$5.79K ﹤0.01% 3711
2024
Q3
$602K Sell
58,127
-15,714
-21% -$163K ﹤0.01% 3404
2024
Q2
$958K Buy
73,841
+8,645
+13% +$112K ﹤0.01% 3224
2024
Q1
$1.14M Sell
65,196
-7,430
-10% -$130K ﹤0.01% 3077
2023
Q4
$683K Sell
72,626
-35,329
-33% -$332K ﹤0.01% 3382
2023
Q3
$1.21M Sell
107,955
-57,838
-35% -$646K ﹤0.01% 3055
2023
Q2
$3.55M Sell
165,793
-1,910
-1% -$40.9K ﹤0.01% 2506
2023
Q1
$6.78M Sell
167,703
-716
-0.4% -$29K ﹤0.01% 2133
2022
Q4
$7.83M Sell
168,419
-5,760
-3% -$268K ﹤0.01% 2065
2022
Q3
$9.04M Buy
174,179
+6,384
+4% +$331K ﹤0.01% 1954
2022
Q2
$7.93M Sell
167,795
-14,906
-8% -$705K ﹤0.01% 2072
2022
Q1
$13M Sell
182,701
-12,760
-7% -$908K ﹤0.01% 1933
2021
Q4
$14.6M Buy
195,461
+12,119
+7% +$906K ﹤0.01% 1898
2021
Q3
$10.4M Buy
183,342
+6,969
+4% +$396K ﹤0.01% 2095
2021
Q2
$7.76M Sell
176,373
-18,009
-9% -$792K ﹤0.01% 2267
2021
Q1
$9.59M Buy
194,382
+1,288
+0.7% +$63.5K ﹤0.01% 2108
2020
Q4
$8.13M Sell
193,094
-3,589
-2% -$151K ﹤0.01% 2109
2020
Q3
$9M Buy
196,683
+5,311
+3% +$243K ﹤0.01% 1908
2020
Q2
$9.61M Buy
191,372
+6,597
+4% +$331K ﹤0.01% 1862
2020
Q1
$9.5M Sell
184,775
-4,542
-2% -$234K ﹤0.01% 1730
2019
Q4
$11.7M Sell
189,317
-6,966
-4% -$430K ﹤0.01% 1879
2019
Q3
$11.8M Buy
196,283
+749
+0.4% +$45K ﹤0.01% 1833
2019
Q2
$16.5M Sell
195,534
-60,823
-24% -$5.13M ﹤0.01% 1668
2019
Q1
$24.5M Buy
256,357
+1,594
+0.6% +$152K 0.01% 1435
2018
Q4
$18M Sell
254,763
-1,683
-0.7% -$119K 0.01% 1540
2018
Q3
$21.9M Buy
256,446
+9,799
+4% +$837K 0.01% 1571
2018
Q2
$28.6M Sell
246,647
-2,729
-1% -$316K 0.01% 1380
2018
Q1
$20.2M Buy
249,376
+75,262
+43% +$6.09M 0.01% 1565
2017
Q4
$10.2M Sell
174,114
-5,832
-3% -$342K ﹤0.01% 1970
2017
Q3
$8.42M Sell
179,946
-12,036
-6% -$563K ﹤0.01% 2068
2017
Q2
$6.91M Sell
191,982
-7,096
-4% -$255K ﹤0.01% 2160
2017
Q1
$6.13M Buy
199,078
+5,022
+3% +$155K ﹤0.01% 2227
2016
Q4
$6.5M Buy
194,056
+2,899
+2% +$97.1K ﹤0.01% 2182
2016
Q3
$5.09M Buy
191,157
+3,416
+2% +$90.9K ﹤0.01% 2229
2016
Q2
$4.14M Sell
187,741
-36,440
-16% -$804K ﹤0.01% 2309
2016
Q1
$6.59M Sell
224,181
-78,673
-26% -$2.31M ﹤0.01% 2047
2015
Q4
$10M Sell
302,854
-22,436
-7% -$741K ﹤0.01% 1842
2015
Q3
$11.8M Buy
325,290
+121,996
+60% +$4.41M ﹤0.01% 1765
2015
Q2
$9.15M Buy
203,294
+40,904
+25% +$1.84M ﹤0.01% 2008
2015
Q1
$4.97M Buy
162,390
+90,001
+124% +$2.76M ﹤0.01% 2318
2014
Q4
$3.68M Buy
72,389
+5,172
+8% +$263K ﹤0.01% 2478
2014
Q3
$2.66M Buy
67,217
+10,546
+19% +$417K ﹤0.01% 2680
2014
Q2
$2.44M Sell
56,671
-32,020
-36% -$1.38M ﹤0.01% 2784
2014
Q1
$3.55M Buy
88,691
+1,051
+1% +$42K ﹤0.01% 2507
2013
Q4
$2.39M Buy
87,640
+20,239
+30% +$552K ﹤0.01% 2779
2013
Q3
$1.55M Buy
67,401
+49,904
+285% +$1.14M ﹤0.01% 3003
2013
Q2
$310K Buy
+17,497
New +$310K ﹤0.01% 3651